Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories

BOTHELL, Washington and VANCOUVER, British Columbia, Jan. 24, 2018 -- (Healthcare Sales & Marketing Network) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization o... Biopharmaceuticals, Licensing Achieve Life Sciences, cytisine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news